UNSPSC 51203204: Tazofelone

This classification denotes an immunosuppressant with the molecular formula C18H27NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) VH2I1JN8Q1, chemically known as 4-thiazolidinone, 5-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-, (+-)- but more generally known as tazofelone, which bears US NIH Compound Identifier 68745. European Medicines Agency schedules Tazofelone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10850MIG.

UNSPSC 51203204 Tazofelone (Commodity) covers pharmaceutical products state and local governments procure through cooperative purchasing agreements and direct buys, though recent opportunities tagged to this code show limited direct alignment with tazofelone itself. The solicitations on file reflect state and local health agencies acquiring pharmaceutical inventory — antibiotics, opioid antagonists, and drug disposal systems — through piggyback contracts, fixed-fee purchasing, and competitive bidding processes. Issuing bodies include state health departments and county public health authorities; the Illinois Department of Public Health and Seminole County, Florida appear in the recent record. Scope varies from multi-year warehouse supply agreements serving statewide distribution to localized community health procurement with quarterly delivery schedules. Contracts typically include 12- to 24-month initial terms with renewal options, fixed pricing, and standard compliance requirements such as E-Verify and drug-free workplace certification.

Activity under this code concentrates in Florida and Illinois based on recent postings. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback contract to Chartwell Rx LLC on August 28, 2026 through the MMCAP Infuse consortium for pharmaceutical warehouse supply (Bid 26482DPHPREPDB53392); this was a completed award, not an open solicitation. Seminole County, Florida issued an IFB (60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and potential FEMA funding. The mismatch between the code name (Tazofelone, a specific anti-inflammatory medication) and the actual pharmaceutical products being solicited signals that this code may not be actively used for its nominal scope in current state and local procurement.